Is FULC stock safe? | Glauxie AI

Q: Is FULC stock safe?

Fulcrum Therapeutics, Inc. (FULC) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Alexander C. Sapir. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet... Employees: 200,000.

Q: What are the risks of investing in FULC?

Identify key risks of investing in FULC — debt, competition, volatility, and sector headwinds.

Q: Is FULC a good long-term investment?

Evaluate FULC as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does FULC have?

Review FULC total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is FULC stock safe?

🦉

Fulcrum Therapeutics, Inc. (FULC)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAlexander C. Sapir

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the...

Key Executives

Name	Title
Alan A. Musso	Chief Financial Officer
Alexander C. Sapir	Chief Executive Officer, President & Director
Bradley E. Bernstein	Founder
Curtis G. Oltmans	Chief Legal Officer, Head of External Affairs & Corporate Secretary
Danny Reinberg	Founder
Gregory Tourangeau	Controller & Principal Accounting Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

FULC Profile Financials

What are the risks of investing in FULC? Is FULC a good long-term investment? How much debt does FULC have?